マルチオミクスの市場規模、シェア、動向分析レポート：製品・サービス別、タイプ別、プラットフォーム別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

マルチオミクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマルチオミクス市場規模は2030年までに63億8,000万米ドルに達し、2024年から2030年までのCAGRは15.29％を記録すると予測されています。

オミックス技術のコスト低下や、民間および公的機関からの投資や資金調達の増加といった要因が市場を牽引すると見られています。また、製薬会社やバイオテクノロジー企業、学術研究機関からの需要増加による市場競争の激化も、予測期間中の市場成長を促進すると予測されています。

技術の向上により、オミックス技術のコストは低下し、研究者がデータセットにアクセスしやすくなり、結果的に市場成長を促進すると予想されます。企業はコスト削減のために技術の進歩に注力しています。例えば、Amazon Web Servicesは2022年11月にAmazon Omics serviceを発表しました。このサービスは、バイオインフォマティクスを考慮したストレージオプションを利用して生のシーケンスデータを保存し、コストを削減します。このように、コストが低下することで、研究者や臨床医がオミックス技術にアクセスしやすくなると予想されます。このようなコスト削減は、マルチオミクスアプローチの採用を増加させると予想されます。

民間および公的参加者からの投資や資金提供の増加は、マルチオミクス製品やサービスの需要を押し上げると予想されます。様々な企業がマルチオミクスプラットフォームや技術の開発に多額の投資を行っています。例えば、2022年1月、Rocheはバイオテクノロジー企業であるFreenomeに2億9,000万米ドルを投資しました。この投資は、早期がん発見のためのマルチオミクスプラットフォームを加速させるために使われました。さらに、2023年5月には、MultiOmic Health社が精密治療薬発見プラットフォーム構築のために620万米ドルの資金調達を完了しました。このように、市場では、資金調達や投資の増加により、さまざまな新規プラットフォームや製品が開発されることが期待されています。

市場関係者が革新的な製品やサービスの開発に重点を置くようになっていることも、市場の需要を前進させる重要な要因です。さまざまな企業が、競争の激化に対応するため、斬新なプラットフォームを開発しています。例えば、2023年2月、Via Scientific, Inc.は、マルチオミクス研究中の複雑なデータと分析作業の自動化をサポートするマルチオミクスアクセラレータプラットフォーム、Foundryを発表しました。このような製品発表は、予測期間中、業界を牽引すると予想されます。

マルチオミクス市場レポートハイライト

• 製品・サービス別では、製品分野が2023年の売上高シェア60.5%で市場を独占しており、これは機器やソフトウェアなどの製品の発売が増加していることに起因しています。
• タイプ別では、バルクマルチオミクスが業界最大の収益貢献者でした。一方、シングルセルマルチオミクスは、複雑な生物学システムを理解するためのシングルセルマルチオミクスの需要増加により、予測期間中17.8%のCAGRで最速の成長が見込まれています。
• プラットフォーム別では、ゲノミクスが2023年の売上シェア40.6%で市場を独占しています。この成長は、このセグメントで利用可能な製品数が多いことに起因しています。
• 用途別では、細胞生物学分野が2023年に38.8%のシェアを占め、世界の業界を席巻しました。対照的に、腫瘍学セグメントは予測期間中に最も高い成長率を記録すると予測されています。
• 最終用途別では、学術・研究機関セグメントが50.7％のシェアで業界最大の収益貢献者でした。これとは対照的に、製薬会社やバイオテクノロジー会社は、創薬や薬剤開発を加速するためのマルチオミクスに対する需要の増加により、最も速い成長が見込まれています。
• 北米は2023年、48.68％の収益シェアで世界業界を支配しており、これは同地域に主要な市場プレーヤーが存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 マルチオミクス市場：製品・サービスのビジネス分析

• セグメントダッシュボード
• 世界のマルチオミクス市場：製品・サービスの変動分析
• 世界のマルチオミクス市場規模・動向分析、製品とサービス別、2018～2030年
• 製品
• サービス

第5章 マルチオミクス市場：タイプのビジネス分析

• セグメントダッシュボード
• 世界のマルチオミクス市場：タイプの変動分析
• 世界のマルチオミクス市場規模・動向分析、タイプ別、2018～2030年
• 単一細胞マルチオミクス
• バルクマルチオミクス

第6章 マルチオミクス市場：プラットフォームのビジネス分析

• セグメントダッシュボード
• 世界のマルチオミクス市場：プラットフォームの変動分析
• 世界のマルチオミクス市場規模・動向分析、プラットフォーム別、2018～2030年
• ゲノミクス
• トランスクリプトミクス
• プロテオミクス
• メタボロミクス
• 統合オミクスプラットフォーム

第7章 マルチオミクス市場：用途のビジネス分析

• セグメントダッシュボード
• 世界のマルチオミクス市場：用途の変動分析
• 世界のマルチオミクス市場規模・動向分析、用途別、2018～2030年
• 細胞生物学
• 腫瘍学
• 神経学
• 免疫学

第8章 マルチオミクス市場：最終用途のビジネス分析

• セグメントダッシュボード
• 世界のマルチオミクス市場：最終用途の変動分析
• 世界のマルチオミクス市場規模・動向分析、最終用途別、2018～2030年
• 学術・研究機関
• 製薬・バイオテクノロジー企業
• その他

第9章 マルチオミクス市場：地域の推定・動向分析

• 地域のダッシュボード
• 市場規模と予測・動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2023年
• 参入企業の概要
  • BD
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global multiomics market, by type, 2018 - 2030 (USD Million)
• Table 5 Global multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 6 Global multiomics market, by application, 2018 - 2030 (USD Million)
• Table 7 Global multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 8 Global multiomics market, by region, 2018 - 2030 (USD Million)
• Table 9 North America multiomics market, by country, 2018 - 2030 (USD Million)
• Table 10 North America multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 11 North America multiomics market, by type, 2018 - 2030 (USD Million)
• Table 12 North America multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 13 North America multiomics market, by application, 2018 - 2030 (USD Million)
• Table 14 North America multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 15 U.S. multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 16 U.S. multiomics market, by type, 2018 - 2030 (USD Million)
• Table 17 U.S. multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 18 U.S. multiomics market, by application, 2018 - 2030 (USD Million)
• Table 19 U.S. multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Canada multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 21 Canada multiomics market, by type, 2018 - 2030 (USD Million)
• Table 22 Canada multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 23 Canada multiomics market, by application, 2018 - 2030 (USD Million)
• Table 24 Canada multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 25 Europe multiomics market, by country, 2018 - 2030 (USD Million)
• Table 26 Europe multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 27 Europe multiomics market, by type, 2018 - 2030 (USD Million)
• Table 28 Europe multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 29 Europe multiomics market, by application, 2018 - 2030 (USD Million)
• Table 30 Europe multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 31 UK multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 32 UK multiomics market, by type, 2018 - 2030 (USD Million)
• Table 33 UK multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 34 UK multiomics market, by application, 2018 - 2030 (USD Million)
• Table 35 UK multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Germany multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 37 Germany multiomics market, by type, 2018 - 2030 (USD Million)
• Table 38 Germany multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 39 Germany multiomics market, by application, 2018 - 2030 (USD Million)
• Table 40 Germany multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 41 France multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 42 France multiomics market, by type, 2018 - 2030 (USD Million)
• Table 43 France multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 44 France multiomics market, by application, 2018 - 2030 (USD Million)
• Table 45 France multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 46 Italy multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 47 Italy multiomics market, by type, 2018 - 2030 (USD Million)
• Table 48 Italy multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 49 Italy multiomics market, by application, 2018 - 2030 (USD Million)
• Table 50 Italy multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 51 Spain multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 52 Spain multiomics market, by type, 2018 - 2030 (USD Million)
• Table 53 Spain multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 54 Spain multiomics market, by application, 2018 - 2030 (USD Million)
• Table 55 Spain multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 56 Denmark multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 57 Denmark multiomics market, by type, 2018 - 2030 (USD Million)
• Table 58 Denmark multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 59 Denmark multiomics market, by application, 2018 - 2030 (USD Million)
• Table 60 Denmark multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Sweden multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 62 Sweden multiomics market, by type, 2018 - 2030 (USD Million)
• Table 63 Sweden multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 64 Sweden multiomics market, by application, 2018 - 2030 (USD Million)
• Table 65 Sweden multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Norway multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 67 Norway multiomics market, by type, 2018 - 2030 (USD Million)
• Table 68 Norway multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 69 Norway multiomics market, by application, 2018 - 2030 (USD Million)
• Table 70 Norway multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific multiomics market, by country, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific multiomics market, by type, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific multiomics market, by application, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 77 Japan multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 78 Japan multiomics market, by type, 2018 - 2030 (USD Million)
• Table 79 Japan multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 80 Japan multiomics market, by application, 2018 - 2030 (USD Million)
• Table 81 Japan multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 82 China multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 83 China multiomics market, by type, 2018 - 2030 (USD Million)
• Table 84 China multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 85 China multiomics market, by application, 2018 - 2030 (USD Million)
• Table 86 China multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 87 India multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 88 India multiomics market, by type, 2018 - 2030 (USD Million)
• Table 89 India multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 90 India multiomics market, by application, 2018 - 2030 (USD Million)
• Table 91 India multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 92 Australia multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 93 Australia multiomics market, by type, 2018 - 2030 (USD Million)
• Table 94 Australia multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 95 Australia multiomics market, by application, 2018 - 2030 (USD Million)
• Table 96 Australia multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 97 Thailand multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 98 Thailand multiomics market, by type, 2018 - 2030 (USD Million)
• Table 99 Thailand multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 100 Thailand multiomics market, by application, 2018 - 2030 (USD Million)
• Table 101 Thailand multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 102 South Korea multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 103 South Korea multiomics market, by type, 2018 - 2030 (USD Million)
• Table 104 South Korea multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 105 South Korea multiomics market, by application, 2018 - 2030 (USD Million)
• Table 106 South Korea multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 107 Latin America multiomics market, by country, 2018 - 2030 (USD Million)
• Table 108 Latin America multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 109 Latin America multiomics market, by type, 2018 - 2030 (USD Million)
• Table 110 Latin America multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 111 Latin America multiomics market, by application, 2018 - 2030 (USD Million)
• Table 112 Latin America multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 113 Brazil multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 114 Brazil multiomics market, by type, 2018 - 2030 (USD Million)
• Table 115 Brazil multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 116 Brazil multiomics market, by application, 2018 - 2030 (USD Million)
• Table 117 Brazil multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 118 Mexico multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 119 Mexico multiomics market, by type, 2018 - 2030 (USD Million)
• Table 120 Mexico multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 121 Mexico multiomics market, by application, 2018 - 2030 (USD Million)
• Table 122 Mexico multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 123 Argentina multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 124 Argentina multiomics market, by type, 2018 - 2030 (USD Million)
• Table 125 Argentina multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 126 Argentina multiomics market, by application, 2018 - 2030 (USD Million)
• Table 127 Argentina multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa multiomics market, by country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa multiomics market, by type, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa multiomics market, by application, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 134 South Africa multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 135 South Africa multiomics market, by type, 2018 - 2030 (USD Million)
• Table 136 South Africa multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 137 South Africa multiomics market, by application, 2018 - 2030 (USD Million)
• Table 138 South Africa multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia multiomics market, by type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia multiomics market, by application, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 144 UAE multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 145 UAE multiomics market, by type, 2018 - 2030 (USD Million)
• Table 146 UAE multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 147 UAE multiomics market, by application, 2018 - 2030 (USD Million)
• Table 148 UAE multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 149 Kuwait multiomics market, by product & service, 2018 - 2030 (USD Million)
• Table 150 Kuwait multiomics market, by type, 2018 - 2030 (USD Million)
• Table 151 Kuwait multiomics market, by platform, 2018 - 2030 (USD Million)
• Table 152 Kuwait multiomics market, by application, 2018 - 2030 (USD Million)
• Table 153 Kuwait multiomics market, by end-use, 2018 - 2030 (USD Million)
• Table 154 Participant's overview
• Table 155 Financial performance
• Table 156 Key companies undergoing expansions
• Table 157 Key companies undergoing acquisitions
• Table 158 Key companies undergoing collaborations
• Table 159 Key companies launching new products
• Table 160 Key companies undertaking other strategies

List of Figures

• Fig. 1 Multiomics market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Multiomics market driver analysis
• Fig. 14 Multiomics market restraint analysis
• Fig. 15 Multiomics market: Porter's analysis
• Fig. 16 Multiomics market: PESTEL analysis
• Fig. 17 Multiomics market: Product & service outlook and key takeaways
• Fig. 18 Multiomics market: Product & service market share analysis, 2023 - 2030
• Fig. 19 Global multiomics by products market, 2018 - 2030 (USD Million)
• Fig. 20 Global multiomics by instruments market, 2018 - 2030 (USD Million)
• Fig. 21 Global multiomics by consumables market, 2018 - 2030 (USD Million)
• Fig. 22 Global multiomics by software market, 2018 - 2030 (USD Million)
• Fig. 23 Global multiomics by services market, 2018 - 2030 (USD Million)
• Fig. 24 Multiomics market: Type outlook and key takeaways
• Fig. 25 Multiomics market: Type market share analysis, 2023 - 2030
• Fig. 26 Global single-cell multiomics by men market, 2018 - 2030 (USD Million)
• Fig. 27 Global multiomics by bulk multiomics market, 2018 - 2030 (USD Million)
• Fig. 28 Multiomics market: Platform outlook and key takeaways
• Fig. 29 Multiomics market: Platform market share analysis, 2023 - 2030
• Fig. 30 Global multiomics by genomics market, 2018 - 2030 (USD Million)
• Fig. 31 Global multiomics by transcriptomics market, 2018 - 2030 (USD Million)
• Fig. 32 Global multiomics by proteomics market, 2018 - 2030 (USD Million)
• Fig. 33 Global multiomics by metabolomics market, 2018 - 2030 (USD Million)
• Fig. 34 Global multiomics by integrated omics platforms market, 2018 - 2030 (USD Million)
• Fig. 35 Multiomics market: Application outlook and key takeaways
• Fig. 36 Multiomics market: Application market share analysis, 2023 - 2030
• Fig. 37 Global multiomics by cell biology market, 2018 - 2030 (USD Million)
• Fig. 38 Global multiomics by oncology market, 2018 - 2030 (USD Million)
• Fig. 39 Global multiomics by neurology market, 2018 - 2030 (USD Million)
• Fig. 40 Global multiomics by immunology market, 2018 - 2030 (USD Million)
• Fig. 41 Multiomics market: End-use outlook and key takeaways
• Fig. 42 Multiomics market: End-use market share analysis, 2023 - 2030
• Fig. 43 Global multiomics by academic and research institutes market, 2018 - 2030 (USD Million)
• Fig. 44 Global multiomics by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 45 Global multiomics by others market, 2018 - 2030 (USD Million)
• Fig. 46 Regional marketplace: Key takeaways
• Fig. 47 North America multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 U.S. key country dynamics
• Fig. 49 U.S. multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Canada key country dynamics
• Fig. 51 Canada multiomics market, 2018 - 2030 (USD Million)
• Fig. 52 Europe multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 UK key country dynamics
• Fig. 54 UK multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Germany key country dynamics
• Fig. 56 Germany multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 France key country dynamics
• Fig. 58 France multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Italy key country dynamics
• Fig. 60 Italy multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Spain key country dynamics
• Fig. 62 Spain multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Denmark key country dynamics
• Fig. 64 Denmark multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Sweden key country dynamics
• Fig. 66 Sweden multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Norway key country dynamics
• Fig. 68 Norway multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Asia-Pacific multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Japan key country dynamics
• Fig. 71 Japan multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 China key country dynamics
• Fig. 73 China multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 India key country dynamics
• Fig. 75 India multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Australia key country dynamics
• Fig. 77 Australia multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Thailand key country dynamics
• Fig. 79 Thailand multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 South Korea key country dynamics
• Fig. 81 South Korea multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Latin America multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Brazil key country dynamics
• Fig. 84 Brazil multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 Mexico key country dynamics
• Fig. 86 Mexico multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Argentina key country dynamics
• Fig. 88 Argentina multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 MEA multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 South Africa key country dynamics
• Fig. 91 South Africa multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Saudi Arabia key country dynamics
• Fig. 93 Saudi Arabia multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 UAE key country dynamics
• Fig. 95 UAE multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 96 Kuwait key country dynamics
• Fig. 97 Kuwait multiomics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 Key company categorization
• Fig. 99 Company market positioning
• Fig. 100 Market participant categorization
• Fig. 101 Strategy framework

Multiomics Market Growth & Trends:

The global multiomics market size is expected to reach USD 6.38 billion by 2030, registering a CAGR of 15.29% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

• Based on product & service, the product segment dominated the market with a revenue share of 60.5% in 2023, which can be attributed to the rising launches of products such as instruments and software
• Based on type, the bulk multiomics held the largest revenue contributor for the industry. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
• Based on platform, genomics dominated the market with a revenue share of 40.6% in 2023. The growth is attributed to the high number of products available in this segment
• Based on application, the cell biology segment dominated the global industry with a share of 38.8% in 2023. In contrast, the oncology segment is projected to register the highest growth rate during the projected period
• Based on end-use, the academic and research institute segment was the largest revenue contributor for the industry, with a share of 50.7%. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
• North America dominated the global industry in 2023 with a revenue share of 48.68%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Type
  • 1.2.3. Platform
  • 1.2.4. Application
  • 1.2.5. End-use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. The increasing interest of researchers in the field of single-cell genomics
    • 3.2.1.2. Rising incidence of chronic diseases
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High initial costs
    • 3.2.2.2. Stringent government policies and regulations
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Multiomics Market Product & Service Movement Analysis
• 4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Product
  • 4.4.1. Global Product Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Instruments
    • 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Consumables
    • 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Software
    • 4.4.4.1. Global Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Multiomics Market Type Movement Analysis
• 5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Single-cell Multiomics
  • 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Bulk Multiomics
  • 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Multiomics Market Platform Movement Analysis
• 6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2018 to 2030 (USD Million)
• 6.4. Genomics
  • 6.4.1. Global Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Transcriptomics
  • 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Proteomics
  • 6.6.1. Global Proteomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Metabolomics
  • 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Integrated Omics Platforms
  • 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

• 7.1. Segment Dashboard
• 7.2. Global Multiomics Market Application Movement Analysis
• 7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Cell Biology
  • 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Oncology
  • 7.5.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Neurology
  • 7.6.1. Global Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Immunology
  • 7.7.1. Global Immunology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

• 8.1. Segment Dashboard
• 8.2. Global Multiomics Market End-use Movement Analysis
• 8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 8.4. Academic & Research Institutes
  • 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Pharmaceutical & Biotechnology Companies
  • 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 9.3. North America
  • 9.3.1. North America Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. Mexico
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Mexico Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. Argentina
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Competitive Scenario
    • 9.6.4.3. Regulatory Framework
    • 9.6.4.4. Argentina Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2023
• 10.4. Participant's Overview
  • 10.4.1. BD
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. Thermo Fisher Scientific Inc.
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. Illumina, Inc
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Danaher
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. PerkinElmer Inc.
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. Shimadzu Corporation
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. Bruker
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. QIAGEN
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. Agilent Technologies, Inc.
    • 10.4.9.1. Overview
    • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. BGI
    • 10.4.10.1. Overview
    • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Strategic Initiatives